Form D · Pharmaceuticals

DESIGNMEDIX INC

Portland, OR · CIK 0001448619

Offering snapshot reported Apr 12, 2017 · SEC filing

Reported sold
$651K
Offering amount: $1.25M
Investors reported
13
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Mar 29, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 12, 2017Initial$651,270No comparison13SEC filing
Jul 16, 2013Initial$525,000No comparison19SEC filing
Jun 17, 2010Amendment$1,175,000$135,000vs Apr 15, 200916SEC filing
Apr 15, 2009Initial$1,040,000No comparisonNot reportedSEC filing
Oct 20, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$39.1K
Finders' fees
$0
Form D file number
021-284641
Series B-2 Preferred Stock Financing
Transaction Fee

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Evonne Sepis143752KEMA Partners · CRD 143752

Source: Form D, filed Apr 12, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Erik Iverson Director
Joseph Jarzembowski Director
David Peyton Director, Executive
Sandra Lee Shotwell Director, Executive
Lynnor B Stevenson Director
James Robert Wilson Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2828 Corbett Avenue Suite 121
Portland, OR, 97201